this massive library of cpp’s owned by the company is one of the reasons I first invested in PYC. As i see it, AI will enhance selection of a likely cpp to suit a given cargo into a targetted cell type. I believe the dollars they are talking is miniscule to the outcome of enhanced selection criteria if successful.
gltah - like many here i am heavily overweight in my portfolio!
Ann: AI Driven Drug Discovery Collaboration with Google Cloud, page-32
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.27 |
Change
0.005(0.40%) |
Mkt cap ! $740.7M | |||
| Open | High | Low | Value | Volume |
| $1.27 | $1.29 | $1.27 | $406.0K | 319.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 13987 | $1.27 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.29 | 1380 | 1 |
View Market Depth
| Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |